# VOYXACT

NDC: 59148-400
Generic name: sibeprenlimab
Labeler / Manufacturer: Otsuka America Pharmaceutical, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20251125

FDA application: BLA761434

## Active ingredients

- SIBEPRENLIMAB: 200 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59148-400"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59148-400
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c8a93b32-0676-4704-86dc-cb65f425c6e5